Angiography contrast medium injection system, line-powered, mobile
Access comprehensive regulatory information for Angiography contrast medium injection system, line-powered, mobile in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Intervene Medical Pty Ltd, manufactured by Angiodroid SpA in Italy. The device registration started on November 02, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The device allows the intravascular injection of CO2, with precise volume dose and injection pressure, to perform Automated Carbon Dioxide Angiography (ACDA). CO2 acts as a contrast agent in an angiographic examination.